Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine. The ...
I have no access to any of the numerous products I purchased, way back in 2018. The products on the app were avail for a couple of yrs, then stopped working. I have been trying to contact this company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results